Skip to main content

Protagonist Therapeutics, Inc

PTGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001377121

In the last 90 days, Protagonist Therapeutics, Inc insiders filed 0 open-market purchases and 3 sales; 346 institutions reported holding it in 13F filings for Q2 2026, worth $9.30B in total; Duquesne Family Office is the only superinvestor holding it.

13F holders, Q4 2023

Institutional positions in Protagonist Therapeutics, Inc as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
157
+14 vs. Q3 2023
Shares held
57.5M
+792.3K (+1.4%) vs. Q3 2023
Total value
$1.32B
+$372.5M (+39.4%) vs. Q3 2023
New holders
33
40 more added
Sold out
19
60 more reduced

1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PTGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2023: 157 institutions
Q1 2021: 127 institutionsQ2 2021: 139 institutionsQ3 2021: 132 institutionsQ4 2021: 149 institutionsQ1 2022: 140 institutionsQ2 2022: 131 institutionsQ3 2022: 133 institutionsQ4 2022: 137 institutionsQ1 2023: 138 institutionsQ2 2023: 167 institutionsQ3 2023: 144 institutionsQ4 2023: 157 institutionsQ1 2024: 185 institutionsQ2 2024: 188 institutionsQ3 2024: 240 institutionsQ4 2024: 241 institutionsQ1 2025: 275 institutionsQ2 2025: 274 institutionsQ3 2025: 275 institutionsQ4 2025: 319 institutionsQ1 2026: 322 institutionsQ2 2026: 346 institutions
Value heldQ4 2023: $1.32B
Q1 2021: $1.15BQ2 2021: $2.16BQ3 2021: $820.8MQ4 2021: $1.68BQ1 2022: $1.19BQ2 2022: $422.1MQ3 2022: $398.9MQ4 2022: $533.3MQ1 2023: $1.22BQ2 2023: $1.57BQ3 2023: $945.9MQ4 2023: $1.32BQ1 2024: $1.73BQ2 2024: $2.05BQ3 2024: $2.78BQ4 2024: $2.44BQ1 2025: $3.15BQ2 2025: $3.92BQ3 2025: $4.70BQ4 2025: $6.18BQ1 2026: $8.31BQ2 2026: $9.30B
Institutions holding PTGX and their total value by quarter
QuarterHoldersValue
Q2 2026346$9.30B
Q1 2026322$8.31B
Q4 2025319$6.18B
Q3 2025275$4.70B
Q2 2025274$3.92B
Q1 2025275$3.15B
Q4 2024241$2.44B
Q3 2024240$2.78B
Q2 2024188$2.05B
Q1 2024185$1.73B
Q4 2023157$1.32B
Q3 2023144$945.9M
Q2 2023167$1.57B
Q1 2023138$1.22B
Q4 2022137$533.3M
Q3 2022133$398.9M
Q2 2022131$422.1M
Q1 2022140$1.19B
Q4 2021149$1.68B
Q3 2021132$820.8M
Q2 2021139$2.16B
Q1 2021127$1.15B

Institutions, Q4 2023

Shares, value and share of portfolio for each institution holding Protagonist Therapeutics, Inc; share changes are against Q3 2023.

Institutions holding PTGX in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Susquehanna International Group, LLP109,683$2.52M0.00%+52,438+91.6%Added
TD Asset Management Inc110,800$2.54M0.00%00.0%Unchanged
Artia Global Partners LP112,340$2.58M1.02%00.0%Unchanged
Opaleye Management Inc.112,700$2.58M0.69%+112,700New
HSBC Holdings PLC119,334$2.74M0.00%−434,971−78.5%Reduced
Ghost Tree Capital, LLC125,000$2.87M1.65%−275,000−68.8%Reduced
Jacobs Levy Equity Management, Inc129,011$2.96M0.01%00.0%Unchanged
Marshall Wace, LLP142,470$3.27M0.01%+120,723+555.1%Added
Barclays PLC148,974$3.42M0.00%−27,863−15.8%Reduced
Millennium Management LLC149,163$3.42M0.00%+149,163New
UBS Group AG150,867$3.46M0.00%+60,141+66.3%Added
Bank of America Corp153,409$3.52M0.00%−85,629−35.8%Reduced
Two Sigma Investments, LP158,843$3.64M0.01%−177,465−52.8%Reduced
Rafferty Asset Management, LLC167,795$3.85M0.02%−182,486−52.1%Reduced
Silvercrest Asset Management Group LLC180,496$4.14M0.03%+340.0%Added
Walleye Capital LLC185,426$4.25M0.06%+51,610+38.6%Added
Driehaus Capital Management LLC198,689$4.56M0.05%+198,689New
ADAR1 Capital Management, LLC200,859$4.61M2.06%+200,859New
Bank of New York Mellon Corp203,177$4.66M0.00%+1,733+0.9%Added
Renaissance Technologies LLC213,967$4.91M0.01%−12,301−5.4%Reduced
Two Sigma Advisers, LP222,000$5.09M0.01%−94,900−29.9%Reduced
Checkpoint Capital L.P.266,856$6.12M4.27%+266,856New
Deep Track Capital, LP275,201$6.31M0.22%+275,201New
UBS Asset Management Americas Inc289,079$6.63M0.00%+218,020+306.8%Added
Kennedy Capital Management, Inc.304,790$6.99M0.15%−14,744−4.6%Reduced
Nuveen Asset Management, LLC305,419$7.00M0.00%−230,605−43.0%Reduced
Ikarian Capital, LLC319,000$7.31M2.00%+319,000New
Superstring Capital Management LP379,143$8.69M6.21%+379,143New
Perceptive Advisors LLC383,260$8.79M0.20%−671,013−63.6%Reduced
Gratus Capital LLC397,571$9.12M0.52%+104,702+35.8%Added
JPMorgan Chase & Co411,046$9.43M0.00%+178,756+77.0%Added
Mangrove Partners439,314$10.1M0.87%00.0%Unchanged
Charles Schwab Investment Management Inc455,321$10.4M0.00%+16,219+3.7%Added
Sio Capital Management, LLC460,044$10.5M2.72%+211,917+85.4%Added
FMR LLC465,952$10.7M0.00%−43,290−8.5%Reduced
StemPoint Capital LP513,681$11.8M3.17%+513,681New
Goldman Sachs Group Inc515,220$11.8M0.00%+48,017+10.3%Added
Candriam Luxembourg S.C.A.537,000$12.3M0.08%−93,000−14.8%Reduced
Eversept Partners, LP538,074$12.3M1.21%+251,326+87.6%Added
Northern Trust Corp550,139$12.6M0.00%−12,549−2.2%Reduced
683 Capital Management, LLC715,000$16.4M1.64%−17,784−2.4%Reduced
Dimensional Fund Advisors LP816,537$18.7M0.01%−124,737−13.3%Reduced
Price T Rowe Associates Inc823,740$18.9M0.00%−8,253−1.0%Reduced
Deutsche Bank AG910,012$20.9M0.01%+838,099+1,165.4%Added
Morgan Stanley1,191,837$27.3M0.00%+762,833+177.8%Added
Geode Capital Management, LLC1,248,284$28.6M0.00%+67,028+5.7%Added
Jefferies Financial Group Inc.1,270,561$29.1M0.46%+435,000+52.1%Added
Adage Capital Partners GP, L.L.C.1,291,701$29.6M0.06%+591,701+84.5%Added
Kynam Capital Management, LP2,004,875$46.0M5.20%+186,218+10.2%Added
Johnson & Johnson2,449,183$56.2M1.28%00.0%Unchanged
Point72 Asset Management, L.P.2,613,453$59.9M0.18%+1,505,313+135.8%Added
State Street Corp2,729,929$62.6M0.00%−1,212,209−30.8%Reduced
Vanguard Group Inc3,153,916$72.3M0.00%−74,478−2.3%Reduced
RTW Investments, LP5,315,514$121.9M1.90%−100,000−1.8%Reduced
BlackRock Inc.5,543,902$127.1M0.00%+314,477+6.0%Added
Farallon Capital Management, L.L.C.5,734,430$131.5M0.82%+288,000+5.3%Added
BVF Inc5,744,848$131.7M3.30%00.0%Unchanged
Cowen and Company, LLC0$00.00%−1,657,551−100.0%Sold out
Braidwell LP0$00.00%−1,109,150−100.0%Sold out
Eventide Asset Management, LLC0$00.00%−320,000−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−177,125−100.0%Sold out
Suvretta Capital Management, LLC0$00.00%−108,308−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−91,735−100.0%Sold out
Healthcare of Ontario Pension Plan Trust Fund0$00.00%−88,000−100.0%Sold out
Federated Hermes, Inc.0$00.00%−60,234−100.0%Sold out
Campbell & CO Investment Adviser LLC0$00.00%−56,577−100.0%Sold out
Ghisallo Capital Management LLC0$00.00%−50,000−100.0%Sold out
Public Sector Pension Investment Board0$00.00%−49,000−100.0%Sold out
Jump Financial, LLC0$00.00%−35,438−100.0%Sold out
XTX Topco Ltd0$00.00%−16,139−100.0%Sold out
Capital Fund Management S.A.0$00.00%−12,629−100.0%Sold out
Franklin Resources Inc0$00.00%−11,853−100.0%Sold out
Sawtooth Solutions, LLC0$00.00%−10,411−100.0%Sold out
Bleakley Financial Group, LLC0$00.00%−10,411−100.0%Sold out
Russell Investments Group, Ltd.0$00.00%−12−100.0%Sold out
CWM, LLC0$00.00%−7−100.0%Sold out
International Biotechnology Trust PLC––––Not filed